Specifically, neither transfer of B6 donor cells deficient in either IL-12R or Ifnar1, nor combined antibody-mediated blockade of both cytokines altered the acute GVHD phenotype at two weeks (manuscript in preparation). The gene discussed is IFNAR1; the disease is graft versus host disease.